These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
286 related items for PubMed ID: 21467254
1. Acute, subacute, and chronic myocardial infarction: quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging. Goetti R, Kozerke S, Donati OF, Sürder D, Stolzmann P, Kaufmann PA, Lüscher TF, Corti R, Manka R. Radiology; 2011 Jun; 259(3):704-11. PubMed ID: 21467254 [Abstract] [Full Text] [Related]
3. Assessment of left ventricular myocardial scar in coronary artery disease by a three-dimensional MR imaging technique. Yin G, Zhao S, Lu M, Ma N, Zuehlsdorff S, Cheng H, Jiang S, Zhao T, Zhang Y, An J, Lv C, He Z. J Magn Reson Imaging; 2013 Jul; 38(1):72-9. PubMed ID: 23225643 [Abstract] [Full Text] [Related]
10. Three-dimensional phase-sensitive inversion-recovery turbo FLASH sequence for the evaluation of left ventricular myocardial scar. Kino A, Zuehlsdorff S, Sheehan JJ, Weale PJ, Carroll TJ, Jerecic R, Carr JC. AJR Am J Roentgenol; 2009 Nov; 193(5):W381-8. PubMed ID: 19843715 [Abstract] [Full Text] [Related]
11. High spatial resolution free-breathing 3D late gadolinium enhancement cardiac magnetic resonance imaging in ischaemic and non-ischaemic cardiomyopathy: quantitative assessment of scar mass and image quality. Bizino MB, Tao Q, Amersfoort J, Siebelink HJ, van den Bogaard PJ, van der Geest RJ, Lamb HJ. Eur Radiol; 2018 Sep; 28(9):4027-4035. PubMed ID: 29626239 [Abstract] [Full Text] [Related]
12. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience. Hori M, Kim T, Onishi H, Ueguchi T, Tatsumi M, Nakamoto A, Tsuboyama T, Tomoda K, Tomiyama N. Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182 [Abstract] [Full Text] [Related]
13. Myocardial viability: breath-hold 3D MR imaging of delayed hyperenhancement with variable sampling in time. Foo TK, Stanley DW, Castillo E, Rochitte CE, Wang Y, Lima JA, Bluemke DA, Wu KC. Radiology; 2004 Mar; 230(3):845-51. PubMed ID: 14990846 [Abstract] [Full Text] [Related]
14. Quantitative comparison of 2D and 3D late gadolinium enhancement MR imaging in patients with Fabry disease and hypertrophic cardiomyopathy. Morsbach F, Gordic S, Gruner C, Niemann M, Goetti R, Gotschy A, Kozerke S, Alkadhi H, Manka R. Int J Cardiol; 2016 Aug 15; 217():167-73. PubMed ID: 27183453 [Abstract] [Full Text] [Related]
15. Gadobutrol for magnetic resonance imaging of chronic myocardial infarction: intraindividual comparison with gadopentetate dimeglumine. Durmus T, Schilling R, Doeblin P, Huppertz A, Hamm B, Taupitz M, Wagner M. Invest Radiol; 2012 Mar 15; 47(3):183-8. PubMed ID: 22183078 [Abstract] [Full Text] [Related]
16. Myocardial Late Gadolinium Enhancement: Accuracy of T1 Mapping-based Synthetic Inversion-Recovery Imaging. Varga-Szemes A, van der Geest RJ, Spottiswoode BS, Suranyi P, Ruzsics B, De Cecco CN, Muscogiuri G, Cannaò PM, Fox MA, Wichmann JL, Vliegenthart R, Schoepf UJ. Radiology; 2016 Feb 15; 278(2):374-82. PubMed ID: 26230908 [Abstract] [Full Text] [Related]
17. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine. Bauner KU, Reiser MF, Huber AM. Invest Radiol; 2009 Feb 15; 44(2):95-104. PubMed ID: 19077911 [Abstract] [Full Text] [Related]
18. Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging. Harrigan CJ, Peters DC, Gibson CM, Maron BJ, Manning WJ, Maron MS, Appelbaum E. Radiology; 2011 Jan 15; 258(1):128-33. PubMed ID: 21045187 [Abstract] [Full Text] [Related]